T

TransCode Therapeutics, Inc.

18 employees

TransCode Therapeutics is a pre-clinical biopharmaceutical company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
CRISPR
Diagnostics
RNA
Orphan Disease Designation
Nucleic Acid Therapeutics
Oncology
Metastasis
Health Care
Checkpoint Inhibitor
Therapeutics
Pattern Recognition Receptor
mRNA vaccine

Date founded

2016

Funding rounds raised

Total raised

$1.1M

from 5 investors over 5 rounds

T

TransCode Therapeutics, Inc. raised undisclosed on April 5, 2023

Investors: National Institutes of Health

T

TransCode Therapeutics, Inc. raised $1.1M on June 1, 2022

Investors: National Cancer Institute

T

TransCode Therapeutics, Inc. raised undisclosed on August 5, 2021

Investors: National Institutes of Health

T

TransCode Therapeutics, Inc. raised undisclosed on July 12, 2021

Investors: Red Cedar Ventures

T

TransCode Therapeutics, Inc. raised undisclosed on August 4, 2014

Investors: Red Cedar Ventures

FAQ